Empowering Process Development for Viral Vector-Based Medicines

Join a 29-minute webinar led by Dr. Matthias Müllner, co-founder of bespark*bio and former Technical Operations leader at Themis Bioscience, exploring innovative approaches to process development for viral vector-based medicines. Discover how combining cutting-edge bioprocessing expertise with modern digitalization and machine-learning techniques creates an efficient CMC pathway. Learn about pre-defined modular building blocks and framework technologies that reduce complexity while offering customizable solutions for process development. Understand how these methodologies accelerate development timelines, enhance process understanding, and minimize failure risks. Earn PACE credits valid until April 2026 by watching the presentation and completing the necessary steps through the Labroots platform.